Abstract
Diabetes presents with a constellation of symptoms,hyperglycemia being just one of them.The primary challenge faced by physicians is to achieve a control over this exorbitant blood sugar levels.Oral antidiabetic agents insulin therapy are the primary modalities of treatment available presently. The most reliable diagnostic as well as prognostic marker used for this purpose is HbA1c. Adenosine Deaminase (ADA), an enzyme associated with purine metabolism is known to exert potent metabolic effects through its receptors. ADA is primarily an established inflammatory marker reflecting T lymphocyte activity .Adenosine,the substrate of ADA is known to affect cholesterol synthesis in liver,thereby serving as a key hinge in the fine balance between glucose lipid homeostasis. Due to the association of ADA with glucose lipid homeostasis ,the authors believe that studying ADA activity in serum of diabetics can reveal many important facts which might open a new dimension in diagnosis treatment protocol for diabetes mellitus.The purpose of our study was to monitor ADA activity in serum of diabetic patients who are on oral antidiabetic drugs do not have evidence of microvascular or macrovascular complications of diabetes also determine if any correlation exists between fasting blood glucose,HbA1c serum ADA activity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
